Medtronic (MDT) Announces Strong RevElution Trial Results for Novel Drug-Filled Stent
Tweet Send to a Friend
Medtronic plc (NYSE: MDT) unveiled the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
